Form 4: Avanos Medical SVP, Operations, Sigfrido Delgado, Reports Acquisition of 16,300 Shares

Sigfrido Delgado, SVP of Operations at Avanos Medical, reports acquiring 16,300 shares of common stock and discloses holdings of 44,119 shares following the transaction.

Summary

• On April 22, 2025, Sigfrido Delgado, SVP of Operations at Avanos Medical, acquired 16,300 shares of Avanos Medical, Inc. common stock.
• These shares were acquired as time-based restricted share units (TRSUs) under the company's 2021 Long Term Incentive Plan, as amended.
• The TRSUs will vest on April 22, 2026.
• Following this transaction, Delgado directly owns 44,119 shares of Avanos Medical common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating an executive's stock acquisition, which is neither overtly positive nor negative.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of the restricted share units in 2026 suggests a long-term incentive for the executive.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the ownership positions of company executives.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company executive.

Key Dates

Keywords

Avanos Medical, Sigfrido Delgado, Form 4, Beneficial Ownership, Insider Trading, AVNS, Restricted Share Units, TRSUs, Long Term Incentive Plan